Exact Mass: 437.1937
Exact Mass Matches: 437.1937
Found 254 metabolites which its exact mass value is equals to given mass value 437.1937
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
fMLP;N-Formyl-MLF
N-Formyl-Met-Leu-Phe (fMLP; N-Formyl-MLF) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR). N-Formyl-Met-Leu-Ph is reported to inhibit TNF-alpha secretion.
Alobresib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
Benzoylphenylalanyl-alanyl-proline
N-Formyl-Met-Leu-Phe
n-Formyl-methionyl-leucyl-phenyl-alanine
(E)-3-(methylsulfonyl)-propenoic acid (2E,6E)-3-hydroxy-4-(8-hydroxy-3,7-dimethyl-2,6-octadienyloxy)-phenethyl amide|sakerinol A
(E)-3-(methylsulfonyl)-propenoic acid (2E,6E)-2-[4-(8-hydroxy-3,7-dimethyl-2,6-octadienyloxy)-phenyl]-2-hydroxyethyl amide|beta-hydroxygerambullol|??-Hydroxygerambullol
Ala Ala Asn Tyr
Ala Ala Tyr Asn
Ala Phe Asn Ser
Ala Phe Ser Asn
Ala Gly Gln Tyr
Ala Gly Tyr Gln
Ala His Asn Pro
Ala His Pro Asn
Ala Asn Ala Tyr
Ala Asn Phe Ser
Ala Asn His Pro
Ala Asn Pro His
Ala Asn Ser Phe
Ala Asn Tyr Ala
Ala Pro His Asn
Ala Pro Asn His
Ala Gln Gly Tyr
Ala Gln Tyr Gly
Ala Ser Phe Asn
Ala Ser Asn Phe
Ala Tyr Ala Asn
Ala Tyr Gly Gln
Ala Tyr Asn Ala
Ala Tyr Gln Gly
Cys Lys Ser Thr
Cys Lys Thr Ser
Cys Ser Lys Thr
Cys Ser Thr Lys
Cys Thr Lys Ser
Cys Thr Ser Lys
Phe Ala Asn Ser
Phe Ala Ser Asn
Phe Gly Asn Thr
Phe Gly Gln Ser
Phe Gly Ser Gln
Phe Gly Thr Asn
Phe Asn Ala Ser
Phe Asn Gly Thr
Phe Asn Ser Ala
Phe Asn Thr Gly
Phe Gln Gly Ser
Phe Gln Ser Gly
Phe Ser Ala Asn
Phe Ser Gly Gln
Phe Ser Asn Ala
Phe Ser Gln Gly
Phe Thr Gly Asn
Phe Thr Asn Gly
Gly Ala Gln Tyr
Gly Ala Tyr Gln
Gly Phe Asn Thr
Gly Phe Gln Ser
Gly Phe Ser Gln
Gly Phe Thr Asn
Gly His Pro Gln
Gly His Gln Pro
Gly Asn Phe Thr
Gly Asn Thr Phe
Gly Pro His Gln
Gly Pro Gln His
Gly Gln Ala Tyr
Gly Gln Phe Ser
Gly Gln His Pro
Gly Gln Pro His
Gly Gln Ser Phe
Gly Gln Tyr Ala
Gly Ser Phe Gln
Gly Ser Gln Phe
Gly Thr Phe Asn
Gly Thr Asn Phe
Gly Tyr Ala Gln
Gly Tyr Gln Ala
His Ala Asn Pro
His Ala Pro Asn
His Gly Pro Gln
His Gly Gln Pro
His Asn Ala Pro
His Asn Pro Ala
His Pro Ala Asn
His Pro Gly Gln
His Pro Asn Ala
His Pro Gln Gly
His Gln Gly Pro
His Gln Pro Gly
Lys Cys Ser Thr
Lys Cys Thr Ser
Lys Ser Cys Thr
Lys Ser Thr Cys
Lys Thr Cys Ser
Lys Thr Ser Cys
Asn Ala Ala Tyr
Asn Ala Phe Ser
Asn Ala His Pro
Asn Ala Pro His
Asn Ala Ser Phe
Asn Ala Tyr Ala
Asn Phe Ala Ser
Asn Phe Gly Thr
Asn Phe Ser Ala
Asn Phe Thr Gly
Asn Gly Phe Thr
Asn Gly Thr Phe
Asn His Ala Pro
Asn His Pro Ala
Asn Pro Ala His
Asn Pro His Ala
Asn Ser Ala Phe
Asn Ser Phe Ala
Asn Thr Phe Gly
Asn Thr Gly Phe
Asn Tyr Ala Ala
Pro Ala His Asn
Pro Ala Asn His
Pro Gly His Gln
Pro Gly Gln His
Pro His Ala Asn
Pro His Gly Gln
Pro His Asn Ala
Pro His Gln Gly
Pro Asn Ala His
Pro Asn His Ala
Pro Gln Gly His
Pro Gln His Gly
Gln Ala Gly Tyr
Gln Ala Tyr Gly
Gln Phe Gly Ser
Gln Phe Ser Gly
Gln Gly Ala Tyr
Gln Gly Phe Ser
Gln Gly His Pro
Gln Gly Pro His
Gln Gly Ser Phe
Gln Gly Tyr Ala
Gln His Gly Pro
Gln His Pro Gly
Gln Pro Gly His
Gln Pro His Gly
Gln Ser Phe Gly
Gln Ser Gly Phe
Gln Tyr Ala Gly
Gln Tyr Gly Ala
Ser Ala Phe Asn
Ser Ala Asn Phe
Ser Cys Lys Thr
Ser Cys Thr Lys
Ser Phe Ala Asn
Ser Phe Gly Gln
Ser Phe Asn Ala
Ser Phe Gln Gly
Ser Gly Phe Gln
Ser Gly Gln Phe
Ser Lys Cys Thr
Ser Lys Thr Cys
Ser Asn Ala Phe
Ser Asn Phe Ala
Ser Gln Phe Gly
Ser Gln Gly Phe
Ser Thr Cys Lys
Ser Thr Lys Cys
Thr Cys Lys Ser
Thr Cys Ser Lys
Thr Phe Gly Asn
Thr Phe Asn Gly
Thr Gly Phe Asn
Thr Gly Asn Phe
Thr Lys Cys Ser
Thr Lys Ser Cys
Thr Asn Phe Gly
Thr Asn Gly Phe
Thr Ser Cys Lys
Thr Ser Lys Cys
Tyr Ala Ala Asn
Tyr Ala Gly Gln
Tyr Ala Asn Ala
Tyr Ala Gln Gly
Tyr Gly Ala Gln
Tyr Gly Gln Ala
Tyr Asn Ala Ala
Tyr Gln Ala Gly
Tyr Gln Gly Ala
D-Cloprostenol methyl amide
(6-Chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1H-isobenzofuran-3,4-piperidine)-1-yl-methanone
N-{(1s,2r)-2-Hydroxy-1-[(Hydroxyamino)carbonyl]propyl}-4-{[4-(Morpholin-4-Ylmethyl)phenyl]ethynyl}benzamide
For-Met-Leu-Phe-OH
N-Formyl-Met-Leu-Phe (fMLP; N-Formyl-MLF) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR). N-Formyl-Met-Leu-Ph is reported to inhibit TNF-alpha secretion.
Benzoylphenylalanyl-alanyl-proline
2-alpha,omega-Hexadecanedioyl-lysophosphatidic acid
1-alpha,omega-Hexadecanedioyl-glycerol-3-phosphate
2-(N-[2-[(2-formamido-4-methylsulfanylbutanoyl)amino]-4-methylpentanoyl]anilino)propanoic acid
4-[[[2-(4-methoxyphenyl)-3-oxo-1H-isoindol-4-yl]-oxomethyl]amino]-1-piperidinecarboxylic acid ethyl ester
(4-Tert-butylphenyl)-[2-(4-fluorophenyl)-8-methyl-3-sulfanylidene-1,4,8-triazaspiro[4.5]dec-1-en-4-yl]methanone
1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(4-methoxyphenyl)-1-(2-oxolanylmethyl)urea
N-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[(1S,3S,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3R,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3S)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[(1R,3S,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
(2R,4S)-2-[(1R)-1-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-2-(butylamino)-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylate
(2S)-2-(2-ethoxyanilino)-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]propanamide
n-(2-hydroxy-2-{4-[(8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]phenyl}ethyl)-3-methanesulfonylprop-2-enimidic acid
β-hydroxygerambullol
{"Ingredient_id": "HBIN018158","Ingredient_name": "\u03b2-hydroxygerambullol","Alias": "NA","Ingredient_formula": "C22H31NO6S","Ingredient_Smile": "CC(=CCOC1=CC=C(C=C1)C(CNC(=O)C=CS(=O)(=O)C)O)CCC=C(C)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10139","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}